Assessing Exposure to Organophosphorus Pesticides by Biomonitoring in Epidemiologic Studies of Birth Outcomes by Needham, Larry L.
494 VOLUME 113 | NUMBER 4 | April 2005 • Environmental Health Perspectives
Children’s Health Commentary
Three recent studies (Berkowitz et al. 2003,
2004; Eskenazi et al. 2004; Perera et al.
2003; Whyatt et al. 2004) appearing in
Environmental Health Perspectives examined the
relation between pregnant women’s exposures
to selected pesticides and birth outcomes. The
participants in each of these studies were likely
exposed to many classes of pesticides as well as
to other environmental chemicals, but the pri-
mary exposure focus of these studies was on
organophosphorus pesticides. Of the approxi-
mately 40 organophosphorus pesticides regis-
tered by the U.S. Environmental Protection
Agency (EPA), chlorpyrifos was used in large
amounts in all three exposure scenarios, and
among the pesticides measured in these
studies, chlorpyrifos or its metabolite 3,5,6-
trichloro-2-pyridinol (TCPy) was detected in
the highest concentrations in the biologic
specimens tested. Exposure to chlorpyrifos
was assessed by measuring it in umbilical cord
and maternal blood samples (Whyatt et al.
2004) and by measuring its speciﬁc metabo-
lite, TCPy, in urine (Berkowitz et al. 2004;
Eskenazi et al. 2004), and is included in
the measurements of a suite of nonspecific
metabolites [dialkyl phosphates (DAPs)] of
organophosphorus pesticides (Eskenazi et al.
2004). All three studies statistically examined
the relation between pesticide exposures and
several birth outcomes, although, like the expo-
sure assessment methods, the birth outcomes
examined were not identical across these stud-
ies. The signiﬁcant relations reported between
their exposure assessments and birth outcomes
included decreased birth size (Whyatt et al.
2004), decreased head circumference with
levels of paraoxonase 1 (PON1) activity as a
modiﬁer (Berkowitz et al. 2004), and decreased
gestational age at birth (Eskenazi et al. 2004).
Further details on the exposure scenarios, expo-
sure assessments in relation to birth outcomes,
and the data analyses are examined.
Exposure Settings
The pathways for the organophosphorus insec-
ticide exposures differ between the California
(Eskenazi et al. 2004) and New York studies
(Berkowitz et al. 2004; Whyatt et al. 2004)
but are probably similar for the two New York
City studies. The major sources of organo-
phosphorus insecticides throughout pregnancy
in the New York studies were assumed to be
recurrent indoor broadcast sprayings, primarily
of chlorpyrifos (Landrigan et al. 1999). The
fate of chlorpyrifos in a setting similar to that
of the New York City studies was reported
by Gurunathan et al. (1998). They found that
after spraying chlorpyrifos, air concentrations
peaked in a two-phase process: an aerosolized
particle phase with chlorpyrifos concentration
peaking on surface areas after 36 hr and a gas
phase that began 12 hr after application and
continued for at least 2 weeks, with chlorpyri-
fos concentrations peaking on surface areas at
72 hr and then declining. Of course, the degree
of ventilation in a particular residence would
affect the amount of chlorpyrifos in the air.
Whyatt et al. (2004) indicated that the insecti-
cides were sprayed repeatedly in the residences
of the pregnant women in their New York
study. Therefore, the chances for repeated
exposures were high.
In the California study (Eskenazi et al.
2004), the primary exposure focus was agricul-
tural applications in the Salinas Valley of several
pesticides, pesticide drift from the spraying, and
the “bringing home” of the pesticides on work-
ers’ clothing; however, pesticides were also
potentially used indoors, for landscape main-
tenance, for insect control, and for prevention
of structural damage (Castorina et al. 2003).
Eskenazi et al. (2004) noted that during preg-
nancy 28% of the California women worked
in the fields, another 14% worked at other
agricultural jobs, and a total of 85% had agri-
cultural workers living in their homes.
Before proceeding further, it is important
to understand the human metabolism and
environmental degradation of organophospho-
rus insecticides, by using chlorpyrifos as an
example (Figure 1). Chlorpyrifos is bioacti-
vated by cytochrome P450–dependent desul-
furation in the liver to chlorpyrifos-oxon. This
oxon is rapidly hydrolyzed to its specific
metabolite TCPy and to diethylphosphate
(DEP) by microsomal esterases, which include
PON1 and chlorpyrifos oxonase, or by nonen-
zymatic hydrolysis (Racke 1993). Alternatively,
chlorpyrifos is dearylated to form TCPy and
diethylthiophosphate (DETP) by microsomal
enzymes or by nonenzymatic hydrolysis. A
complicating factor in interpreting chlorpyri-
fos metabolite concentrations in urine is that
these human metabolites and their environ-
mental degradates are the same chemicals.
Hence, assuming these degradates are excreted
unchanged, measuring chlorpyrifos metabo-
lites in urine does not distinguish exposure to
chlorpyrifos from exposure to the environmen-
tal degradates. In general, organophosphorus
pesticides are metabolized by these routes, and
about 75% of the 40 or so organophosphorus
pesticides that are registered by the U.S. EPA
are biotransformed to DETP, DEP, or four
other DAPs that are excreted in urine and
measured in the same analytical method
(Bravo et al. 2004). Castorina et al. (2003)
noted that although many organophosphorus
pesticides were used in the Salinas Valley, the
applied amount of chlorpyrifos was similar to
that of oxydemeton-methyl but less than that
of either malathion or diazinon for each of the
years 1999–2001. Eskenazi et al. (2004) exam-
ined urinary levels of the speciﬁc metabolites
of these pesticides, except for oxydemeton-
methyl, and found TCPy, the chlorpyrifos
metabolite, much more frequently and in
much higher concentrations in their cohort
than the specific metabolites of malathion
(malathion dicarboxylic acid; MDA) and
diazinon (2-isopropyl-4-methyl-6-hydroxy-
pyrimidine); for example, the median urinary
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above the method’s limit of detection (LOD)
for TCPy and MDA were 3.3 µg/L and 77%
and 0.2 µg/L and 30%, respectively. Acephate
was also used in the Salinas Valley, but expo-
sure to it was not examined
Thus, the organophosphorus insecticides
applied and the environmental settings in
New York and California differed. From the
“exposure scenario” information, one could
assume that the amount and rate of exposure
to pesticides and the type of pesticides were
similar in the two New York studies, but
direct comparisons of exposure with the
California study are difﬁcult. Compounding
this difficulty, within the California study
population, Eskenazi et al. (2004) noted sev-
eral exposure scenarios. Some general com-
parisons can be made, however, between
indoor and outdoor settings. Because of the
environmental conditions, such as availability
of water and ultraviolet light, which promote
hydrolysis, organophosphorus pesticides tend
to have a longer half-life indoors compared
with outdoors. Therefore, in indoor settings,
the ratio of the concentrations of parent pesti-
cide to the less biologically active environ-
mental degradates of the pesticide was likely
higher than in outdoor settings. Also, a higher
percentage of the cumulative exposures to
organophosphorus pesticides in the indoor
settings was probably derived from inhalation
because of the pesticides’ longer duration in
the homes and the amount of time people
spend indoors, including sleeping; thus, the
New York City populations were probably
more continuously exposed to the applied
pesticides. In addition, the indoor broadcast
spraying may have led to increased nondietary
ingestion of chlorpyrifos by New York partic-
ipants compared with the participants in the
California study. In California, the bulk of the
pesticides were applied in agricultural fields,
although some indoor use for insect control
occurred. Therefore, especially among the
California agricultural workers, more dermal
exposure may have been experienced.
Exposure Assessment
The overarching issue regarding the exposure
assessment concerns the dose of the biologi-
cally active chemical at the target site, which in
these studies is the developing fetus. Figure 2
shows the three routes of exposure for and the
toxicokinetics (absorption, distribution, metab-
olism, and elimination) of a nonpersistent pes-
ticide in the pregnant woman. The route of
exposure can play a role in the relative amount
of fetal exposure to chlorpyrifos and other
organophosphorus insecticides. For example, if
the route is ingestion, much of the chlorpyrifos
may be metabolized to TCPy in the ﬁrst pass
effect before chlorpyrifos reaches the maternal
systemic blood supply and hence the placenta
(Figure 2). After oral administration of chlor-
pyrifos to the rat, Timchalk et al. (2002) indi-
cated that chlorpyrifos was readily absorbed
and metabolized, with peak blood chlorpyrifos
levels observed by 3 hr after dosing. The
amount of unmetabolized chlorpyrifos in
blood after dosing was low: 100-fold lower
than TCPy, according to rat and human stud-
ies of Nolan et al. (1984) and Timchalk et al.
(2002). In addition, Nolan et al. (1984) found
that the terminal elimination half-life of TCPy
in human blood was 27 hr and that 70% of
the oral dose of chlorpyrifos was eliminated
as TCPy in urine within 4 days of exposure.
Timchalk et al. (2002) could not detect the
chlorpyrifos-oxon after the oral administration
of chlorpyrifos at 0.5–2 mg/kg in 12 human
volunteers. However, regardless of the expo-
sure route, the absorbed dose is mostly metabo-
lized, and the TCPy metabolite is distributed
throughout the body in the blood and elimi-
nated through the kidney (Figure 2). Because
the toxicokinetics of administered TCPy or the
DAPs metabolites have not been studied in
similar detail as chlorpyrifos, we do not know
their toxicokinetics, particularly if their elimi-
nation products are TCPy or DAPs or some
other chemicals. For example, findings from
one animal study suggest that exposure to DEP
would result predominantly in the excretion of
inorganic phosphate (Imaizumi et al. 1993),
but the metabolic fate of DAPs is not known
for humans. If TCPy and DAPs are the pri-
mary excreted chemicals after exposure to
them, measurement of these metabolites may
overestimate exposure to chlorpyrifos or other
organophosphorus insecticides depending on
the exposure pathway (Morgan et al. 2004).
As noted in Figure 2, chlorpyrifos is
distributed within the body by the systemic
circulatory system. The amount of parent
chlorpyrifos in the blood of the women in
these three studies obviously depended on the
concentration of chlorpyrifos and the route in
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Figure 1. Human metabolism of chlorpyrifos. 
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Figure 2. Transfer of environmental chemicals from pregnant woman to fetus.the most recent exposure, the exposure rate,
the time interval since the last exposure, and
their individual characteristics, including preg-
nancy, which affect the toxicokinetics of chlor-
pyrifos. However, the amount of parent
chlorpyrifos in maternal blood also depended
on the amount of chlorpyrifos equilibrated, as
a result of previous exposures, with its concen-
tration in adipose tissue, which is a storage site
for chlorpyrifos and other lipophilic chemicals.
Because of its lipophilicity (log Kow = 4.82)
(McCall et al. 1980), chlorpyrifos tends to
store in the body’s adipose tissue, but because
of its high rate of metabolism, chlorpyrifos has
a half-life in the adipose tissue of rats of only
62 hr (Smith et al. 1967). In humans, concen-
trations of chlorpyrifos in maternal blood and
adipose tissue are likely to be in steady state
with each other and with its concentration in
fetal blood unless the blood samples are taken
very soon after exposure to chlorpyrifos.
Whyatt et al. (2004) showed that chlorpyrifos
concentrations in maternal and cord plasma
samples were correlated (r = 0.76; p < 0.001,
Spearman’s rank). This finding suggests the
potential use of maternal blood for assessing
exposure to organophosphorus insecticides,
although Whyatt et al. (2004) did not describe
whether a relation existed between maternal
blood concentrations of chlorpyrifos and these
birth outcomes. The major advantages of using
maternal blood rather than cord blood are ease
of collection and ability to obtain multiple
samples to evaluate concentrations at different
times during gestation. Of course, the main
advantage of using cord blood rather than
maternal blood is that the former is in direct
contact with the fetus, the target site in these
studies. Therefore, for assessing effects to the
fetus, maternal or cord blood concentrations of
chlorpyrifos may be better indicators than the
less direct indicators of maternal urine TCPy
concentrations. The reasons for this include
the use of the blood samples as surrogates for
the fetus and the speciﬁcity of measuring the
parent chemical (Lu et al. 2004; Morgan et al.
2004; Wilson et al. 2003). That Whyatt et al.
(2004) showed the relation for cord blood
chlorpyrifos levels with newborn growth decre-
ments, but were unable to associate them with
self-reported use or air monitoring measure-
ments, suggests that measures more proximate
to the site of action may be more predictive of
an effect, a main tenet of biomonitoring.
Measuring urine levels of nonpersistent
chemicals and their metabolites is widely
accepted in occupational and environmental
settings, so this approach warrants considera-
tion. In general, the measurement of metabo-
lites of organophosphorus metabolites in urine
allows several advantages: assessing an inte-
grated exposure when blood concentrations are
changing, allowing a more detectable measure
of exposure assessment because of the higher
urinary concentrations, allowing multiple
determinations throughout pregnancy with
noninvasive sampling, in some cases measuring
an active metabolite, assessing exposure to
one specific organophosphorus pesticide or
perhaps to a few (e.g., measurement of TCPy
potentially assesses exposure to both chlorpyri-
fos and chlorpyrifos-methyl), and assessing
exposure to multiple organophosphorus insec-
ticides [about three-fourths of the U.S. EPA–
registered organophosphorus pesticides form
six DAP metabolites (Barr et al. 1999; Barr
and Needham 2002; Needham and Sexton
2000)]. However, measurement of TCPy in
urine, as was done in the studies by Eskenazi
et al. (2004) and Berkowitz et al. (2004), does
not differentiate among exposure to TCPy,
chlorpyrifos, and chlorpyrifos-methyl.
Another advantage of analyzing urine for
metabolites of chlorpyrifos and other organo-
phosphorus pesticides is that we are able to
compare these concentrations with concentra-
tions reported in the U.S. general population
from the National Health and Nutrition
Examination Survey (NHANES) [Centers for
Disease Control and Prevention (CDC) 2003;
Barr et al. 2004; Needham et al., in press].
However, these NHANES data contain only
96 pregnant women, and we do not know the
effect of pregnancy on the toxicokinetics (rates
of absorption, distribution, metabolism, and
elimination) of chlorpyrifos, so urinary TCPy
concentrations in pregnant women and the
concentrations in the NHANES data should be
compared with caution. These U.S. data show
that most of the U.S. general population is
exposed to chlorpyrifos, chlorpyrifos-methyl,
their oxons, TCPy, or a combination of these
chemicals. The median and geometric mean
urinary TCPy concentrations in 1,022 samples
from females 6–59 years of age in 1999–2000
were 1.50 and 1.63 µg/L, respectively. TCPy
was detected in > 91% of the NHANES sam-
ples; this high percentage of detectable concen-
trations implies ubiquitous exposure, probably
primarily through the food chain. In these three
research studies, however, exposure from other
environmental media and routes might pre-
dominate. In the studies by Berkowitz et al.
(2004) and Eskenazi et al. (2004), exposure
assessment methods included the measurement
of urinary concentrations of TCPy at one and
two times during pregnancy, respectively. The
median levels of urinary TCPy differed between
the two studies: 7.6 µg/L for the Berkowitz
et al. study (2004) and 3.3 µg/L for the
Eskenazi et al. study (2004). Because of the
large number (57%) of concentrations below
the method’s LOD and the imputation of con-
centrations below the LOD, the median value
of 7.6 µg/L was below the reported LOD of
11.0 µg/L for the analytical method (high-
performance liquid chromatography–ultraviolet
light detection) that Berkowitz et al. (2004)
employed. Such imputations are subject to a
great deal of inaccuracy, and perhaps this is
one reason Berkowitz et al. (2004) compared
newborn outcome data and exposure data by
dividing the urinary TCPy concentrations into
two groups: mothers with urinary TCPy con-
centrations below the LOD of 11.0 µg/L
(57%) and those with concentrations equal to
or above the LOD (43%). Of course, this
value of 11.0 µg/L was chosen on an analytical,
rather than a biologic, basis and thus may have
no biologic relevance. Compared with the
TCPy concentrations found in the NHANES
data, the concentration of 11.0 µg/L is above
the 95th percentile of all females 6–59 years of
age (95th percentile = 10.0 µg/L), above the
95th percentile for all Mexican Americans
(7.40 µg/L), above the 95th percentile for all
non-Hispanic whites (10 µg/L), but below the
95th percentile for all non-Hispanic blacks
(13.0 µg/L) (CDC 2003). In the study by
Berkowitz et al. (2004), those mothers with
TCPy urinary concentrations above 11.0 µg/L
and with low PON1 activity tended to give
birth to infants with smaller head circumference.
Eskenazi et al. (2004) compared the new-
born outcome data with maternal TCPy con-
centrations below their LOD (0.26 µg/L),
with TCPy concentrations above the detec-
tion limit but below the median urinary
TCPy concentration of 3.3 µg/L, and with
TCPy concentrations equal to or greater than
that median concentration. As in the
Berkowitz et al. (2004) study, no known bio-
logic basis exists for using this 3.3 µg/L value,
although the median value is often used for
such comparisons. The median urinary levels
of TCPy in the Eskenazi et al. study (2004)
are similar to the 75th percentile in the U.S.
population, in which the 75th percentile for
all females was 3.30 µg/L and for all Mexican
Americans was 3.20 µg/L (CDC 2003).
However, the percentage of TCPy urinary con-
centrations above the LOD in the NHANES
population was higher (91%) than in the
Eskenazi et al. study (76%) even though
Eskenazi et al. (2004) reported using a slightly
lower LOD (0.26 vs. 0.4 µg/L); the Eskenazi
et al. (2004) and the NHANES urinary
metabolite data were measured by high-
performance liquid chromatography–tandem
mass spectrometry in the CDC laboratory.
As mentioned above, the California setting
involved agricultural applications of several
organophosphorus insecticides; therefore, in
addition to measuring more speciﬁc metabo-
lites, such as TCPy, Eskenazi et al. (2004)
measured the nonspecific DAPs, which are
metabolites of most of the organophosphorus
pesticides but not of all (e.g., acephate). The
median levels of the dimethyl and diethyl
phosphates for adults, females, and Mexican
Americans are slightly less than the 75th per-
centiles of the U.S. NHANES estimates
Children’s Health | Needham
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(2004) in their study in the Salinas Valley
reported the median concentrations of the
sum of the three dimethyl phosphates was
101 nmol/L. In comparison, for the 75th
percentile for all Mexican Americans in
NHANES, the concentrations were as follows:
dimethylphosphate, 30.2; dimethylthio-
phosphate, 70.4; and dimethyldithiophos-
phate, 11.4 nmol/L. Similarly, for the diethyl
phosphates, Eskenazi et al. (2004) reported
a median concentration of 22 nmol/L. In
NHANES, the concentrations for the 75th
percentile for all Mexican Americans were
as follows: DEP, 26.6; DETP, 4.9; and
diethyldithiophosphate, 1.7 nmol/L. It would
be advantageous to have comparison data for
pregnant women and for the relevant age
groups from NHANES, but nonetheless these
DAPs and TCPy data are consistent in
indicating that the metabolite data for the
California population were approximately
in the 75th percentile of various NHANES
populations.
The studies by Perera et al. (2003) and
Whyatt et al. (2004) also used multiple regres-
sion analyses to evaluate their blood chlorpyri-
fos data. If the data indicated an association
between concentrations of chlorpyrifos and a
newborn outcome, fetal chlorpyrifos concen-
trations were categorized into four exposure
groups to evaluate the dose–response relations.
In so doing, the researchers observed the birth
effects of shorter length and lower weight prin-
cipally when comparing effects in newborns
with concentrations of fetal blood chlorpyrifos
below their LOD (31%) with the highest fetal
blood chlorpyrifos concentrations.
Conclusions
The intent of the three studies was to compare
fetal exposures to selected insecticides, primar-
ily organophosphorus insecticides, with various
birth outcomes. The purpose of this commen-
tary is to examine these studies and discuss
reasons why they did not show consistent rela-
tionships between exposure and birth out-
comes. Most likely, the different conclusions
were not related to errors in birth outcome
measurements, although one cannot assume
that the birth outcome measurements are accu-
rate because they were not standardized or
quality controlled for these studies. Differences
in toxicokinetics and toxicodynamics (i.e.,
essentially how people “handle” and “respond”
to the chemical exposures) may play a role in
the birth outcomes (Needham et al. 2004).
Race/ethnicity can inﬂuence both a chemical’s
toxicokinetics and toxicodynamics. Whyatt
et al.’s (2004) study population self-identiﬁed
as being African American or Dominican;
Berkowitz et al.’s (2004) study population was
categorized in increasing numbers as white,
African American, and Hispanic; and Eskenazi
et al.’s (2004) study population was primarily
Mexican American. Berkowitz et al. (2004)
reported that when maternal PON1 activity
was taken into account, low maternal PON1
activity and TCPy levels above the LOD were
associated with decreased head circumference;
however, the effect of PON activity on the
outcome measures was not evaluated in the
other studies. It would be of interest to know
whether low PON1 activity was dependent on
race/ethnicity. Sex can also be a factor in inﬂu-
encing both toxicokinetics and toxicodynam-
ics. Although the presence of different sexes is
not a factor here, female rats have shown
increased risk to chlorpyrifos-induced toxicity
compared with male rats (Chambers and
Chambers 1989; Sultatos 1991), but bulls have
shown more toxic effects than steers (castrated
bulls) (Haas et al. 1983).
Of course, the exposure setting can play a
role. Although the primary pathways and
routes of exposure differ in the New York and
California studies, it is not possible to compare
the relative degrees of exposure in the Whyatt
et al. study (2004) with the other two studies
because the exposure dosimeters differ so dra-
matically. In the California study, it appears
that exposure to chlorpyrifos is less than in the
New York Berkowitz et al. (2004) study, but
both populations, especially the California
population, were potentially exposed to many
other organophosphorus pesticides that could
have affected birth outcomes. Therefore,
because of the different exposure assessments
used and the inherent difficulties associated
with assessing exposures to nonpersistent
chemicals, it is not possible to reliably compare
the degree of exposure across these studies.
As with any epidemiologic study, we must
take advantage of the strengths and weaknesses
of these three studies and design and conduct
future studies that shed more light on the rela-
tion between maternal chlorpyrifos exposure
and birth outcomes. The epidemiologic stud-
ies should be designed to ensure participation
of a sufficient number of participants with a
wide range of chlorpyrifos exposures. Multiple
exposure assessments, including environmen-
tal measurements, should be conducted to
allow comparison of these studies with the
results of future studies and also to more fully
assess a) fetal exposures using umbilical cord
blood measurements of chlorpyrifos and
TCPy, b) maternal blood concentrations of
the same chemicals obtained during the sec-
ond and third trimesters, and c) TCPy and
DAP concentrations on volume and creati-
nine-adjusted bases in urine collected during
the second and third trimesters and analyzed
with PON1 activity. These biologic specimens
should be taken in a uniform, controlled
manner using a strict protocol. The analytical
methods used should be compared to ensure
that resulting data are of similar quality; thus,
the laboratories involved should compare data
and methods in terms of precision, accuracy,
and LODs before the analyses of study sam-
ples. Also, the data should be analyzed using
similar statistical approaches. Because the blood
chlorpyrifos concentration depends somewhat
on the equilibrium between its concentrations
in adipose tissue and blood, the blood (mater-
nal and cord) concentrations should be evalu-
ated on both a concentration basis and a lipid
basis, as is done when measuring serum dioxin
levels; the lipid-based measurements would
adjust the concentrations in the plasma accord-
ing to the lipid content of the plasma. The lipid
concentration of the plasma affects the equi-
librium of chlorpyrifos between adipose tissue
and plasma and thus the amount of poten-
tially bioavailable chlorpyrifos. Factors such as
pregnancy, recent ingestion of a meal, and
endogenous factors can affect blood lipid con-
centrations (Phillips et al. 1989). To glean as
much information as possible, researchers
should collect maternal blood and ﬁrst-morn-
ing void urine samples on the day after chlor-
pyrifos application as well as on a day well
removed from the day of application. A prob-
lem in duplicating the exposure scenario of the
New York studies is that the indoor application
of chlorpyrifos is no longer lawful in the United
States. An international site that allows duplica-
tion of the conditions that existed when the
studies in New York were conducted may be
needed for future human studies or, if possible,
relevant stored samples from these three studies
should be used.
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